Kaletra
Product Images NDC 11819-342

5 FDA label images from Hhs/program Support Center/supply Service Center · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Kaletra (NDC 11819-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hhs/program Support Center/supply Service Center, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Body Surface Area Equation. (Kaletra 01)

Body Surface Area Equation. (Kaletra 01)
Chemical structure diagram showing a mathematical formula for calculating body surface area (BSA) in square meters, expressed as the square root of height in centimeters multiplied by weight in kilograms divided by 3600.*
FDA Label Image

Chemical Structure For Lopinavir. (Kaletra 02)

Chemical Structure For Lopinavir. (Kaletra 02)
Chemical structure of the active ingredient in Kaletra, showing its molecular components and arrangement of atoms and bonds.*
FDA Label Image

Chemical Structure For Ritonavir. (Kaletra 03)

Chemical Structure For Ritonavir. (Kaletra 03)
Chemical structure diagram associated with the active ingredient(s) of Kaletra, depicting the molecular framework with various functional groups and stereochemistry as shown in the diagram.*
FDA Label Image

Figure Displays Steady-state Plasma Concentrations For Lopinavir And Ritonavir. (Kaletra 04)

Figure Displays Steady-state Plasma Concentrations For Lopinavir And Ritonavir. (Kaletra 04)
A line graph showing plasma concentration (µg/mL) of Lopinavir and Ritonavir over 12 hours. Lopinavir concentration is represented by solid black circles, and Ritonavir by open circles. Dashed lines indicate the 95% confidence interval around the concentration curves.*
FDA Label Image

Principal Display Panel (20 Tablet Bottle Label)

Principal Display Panel (20 Tablet Bottle Label)
Kaletra packaging label showing the active ingredients Lopinavir and Ritonavir tablets with strengths 200 mg and 50 mg respectively. The label indicates a package count of 20 tablets, labeled by HHS/Program Support Center/Supply Service Center, Perry Point, MD. The NDC number 11819-342-20 is also visible along with usage instructions and warnings about storage and safety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.